Market Capitalization Changement Date
AbbVie USD 313.64B 40.03B 2024-03
Acorda Therapeutics USD 16M 2M 2023-06
Amgen USD 148.35B 5.79B 2024-03
Arrowhead Research USD 3.37B 84M 2024-03
AstraZeneca GBP 164.29B 7.78B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 31.4B 6.09B 2024-03
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Enanta Pharmaceuticals USD 198M 37M 2023-12
Gilead Sciences USD 90.93B 10.01B 2024-03
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Halozyme Therapeutics USD 5.12B 237M 2024-03
Heron Therapeutics USD 145M 6M 2023-09
Immunic USD 68M 2M 2023-12
Incyte USD 12.89B 1.18B 2024-03
Insmed USD 3.95B 486M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
J&J USD 375.41B 1.91B 2024-03
Ligand Pharmaceuticals USD 1.26B 19M 2024-03
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Novavax USD 684M 43M 2023-09
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Enanta Pharmaceuticals Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.